Invention Grant
- Patent Title: Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease
-
Application No.: US15558084Application Date: 2016-03-14
-
Publication No.: US10912751B2Publication Date: 2021-02-09
- Inventor: Roger Schofield Newton , Noah Laban Rosenberg , Diane Elaine MacDougall
- Applicant: Esperion Therapeutics, Inc.
- Applicant Address: US MI Ann Arbor
- Assignee: Esperion Therapeutics, Inc.
- Current Assignee: Esperion Therapeutics, Inc.
- Current Assignee Address: US MI Ann Arbor
- Agency: Goodwin Procter LLP
- International Application: PCT/US2016/022319 WO 20160314
- International Announcement: WO2016/149191 WO 20160922
- Main IPC: A61K31/397
- IPC: A61K31/397 ; A61K31/20 ; A61K31/194
Abstract:
Disclosed herein are compositions comprising fixed doses of ETC-1002 and Ezetimibe. Also disclosed herein are methods for using fixed doses of ETC-1002 and Ezetimibe. Uses include methods of treating cardiovascular disease or reducing the risk of cardiovascular disease in a subject. Uses also include methods of treating hypercholesterolemia in a subject.
Public/Granted literature
Information query
